Unknown

Dataset Information

Symptoms and ocular findings associated with administration of 0.01% atropine in young adults.


ABSTRACT:

Clinical relevance

This paper provides eye care practitioners with important information about the potential side effects of 0.01% atropine.

Background

Eye care practitioners routinely administer 0.01% atropine eye drops nightly to slow the progression of myopia, but nobody has assessed accommodative lag or facility, near phoria, intraocular pressure or comfort of drop administration.

Methods

All 21- to 30-year-old adults with no history of accommodative issues or therapy were eligible. During the baseline visit, participants underwent testing related to potential side effects. Participants then administered one drop of 0.01% atropine nightly to both eyes, and all tests were repeated 1 week later.

Results

The average ± standard deviation age of the 31 participa

SUBMITTER: Cyphers B 

PROVIDER: S-EPMC9903161 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature